Interstitial Lung Disease Clinical Trials

29 studies are recruiting for interstitial lung disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

New York, New York 7 Durham, North Carolina 6 Kansas City, Kansas 6 Bend, Oregon 5 Charleston, South Carolina 5 Cincinnati, Ohio 5 Los Angeles, California 5 Rochester, Minnesota 5 Aurora, Colorado 4 Boston, Massachusetts 4 Chicago, Illinois 4 Dallas, Texas 4 Houston, Texas 4 Louisville, Kentucky 4 Philadelphia, Pennsylvania 4 Richmond, Virginia 4 Salt Lake City, Utah 4 Tampa, Florida 4 Ann Arbor, Michigan 3 Naples, Florida 3 New Orleans, Louisiana 3 Phoenix, Arizona 3 Rochester, New York 3 San Francisco, California 3

Studies, page 2

  1. Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough

    This research study is evaluating the effectiveness of escalating doses of Amitriptyline and Duloxetine in reducing cough frequency in patients with interstitial lung disease (ILD)-related cough.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Mayo Clinic in Rochester, Rochester, Minnesota
    Run by
    Mayo Clinic

    See if you can join NCT05120934 on ClinicalTrials.gov

  2. Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

    The purpose of this study is to develop and evaluate the usefulness of MRI using 129Xe gas for regional assessment of pulmonary function. Specifically, three forms of 129Xe MRI contrast will be the investigators focus - 1) imaging of the 129Xe ventilation distribution, 2) imaging the alveolar micro…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Duke University Medical Center, Durham, North Carolina
    Run by
    Bastiaan Driehuys

    See if you can join NCT01280994 on ClinicalTrials.gov

  3. Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

    This is a 2-Part study with Part A, a double-blind, randomized, placebo-controlled, PoC study to evaluate the efficacy, safety, and tolerability of efzofitimod in patients with SSc-ILD. The primary objective of the study is to evaluate the PoC for efficacy in a population with SSc-ILD. While improv…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    aTyr Investigative Site, Los Angeles, California
    Locations
    15 in total
    Run by
    aTyr Pharma, Inc.

    See if you can join NCT05892614 on ClinicalTrials.gov

  4. Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progressi…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    University of California San Francisco, San Francisco, California
    Locations
    4 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT06397677 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.